Vivesto Stock

Vivesto Net Margin

Net Profit Margin of Vivesto (VIVE.ST) as of Aug 10, 2026.

Net Margin

0.00

Last updated:

Net Profit Margin of Vivesto is 2026 0.00 . Net Profit Margin of Vivesto was 2025 -360.31 % . It decreases by % higher compared to the previous year.

For Vivesto, the net margin of -36,031.4% is down versus -10,166.9% a few years ago.

Access this data via the Eulerpool API

Vivesto Stock analysis

What does Vivesto do? Oasmia Pharmaceutical AB is a Swedish pharmaceutical company that specializes in the development and marketing of innovative cancer and pain medications. The company was founded in 1998 and is headquartered in Uppsala, Sweden. Vivesto is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vivesto stock

On Eulerpool you can find the complete historical development of Net Profit Margin Vivesto since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's Vivesto with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

Margins — Vivesto

All Key Metrics — Vivesto